It has been reported that LPS leads to a stronger inflammasome activation (NLRP3) and subsequently a stronger imbalance between pro-inflammatory (increase in IL-20) and anti-inflammatory signals (reduced IL-1, IL-10 expression) in CRMO patient samples [14, 29]. The gene discussed is IL20; the disease is chronic recurrent multifocal osteomyelitis.